Top vaccine makers predict a vaccine or vaccines may be available as early as the beginning of 2021 and at least two pledged doses will be free or low-cost for all Americans. Speaking before a House…
The 1st experimental COVID-19 vaccine in the US revved up people's immune systems just the way scientists had hoped, researchers reported Tuesday. The vaccine will undergo its most important test lat…
Europe Markets Published: July 15, 2020 at 3:59 a.m. ET ASML, Burberry shares down after corporate updates Tourists stroll in downtown Rovinj, on the Istrian peninsula in the Adriatic Sea, on July 4, 2020. Denis Lovrovic/Agence France-Presse/Getty Images European stocks rose on Wednesday, with U.S. equity futures also climbing, as investors embraced positive news surrounding…
The first coronavirus vaccine to be tested in the U.S. boosted the immune systems of the study's participants and is being hailed a major step in the right direction towards eradicating COVID-19.“No matter how you slice this, this is good news,” Dr. Anthony Fauci told The Associated Press.The vaccine, which was developed by researchers at the National…
Need help? Contact us We've detected unusual activity from your computer network To continue, please click the box below to let us know you're not a robot. Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review…
Moderna is aiming to begin its final phase of testing for its coronavirus vaccine July 27.The Cambridge, Massachusetts-based biotech company is the first to announce an estimated start date for phase 3 trials in the United States.Full coverage of the coronavirus outbreak Information about the trial, including guidance for vaccine volunteers, was posted on clinicaltrials.gov…
As the race to develop a vaccine for the coronavirus speeds up, the pharmaceutical industry is being careful to not set any dangerous precedent that may weaken their future intellectual property rights, a senior executive at IHS Markit said Thursday. The World Health Organization this week published an update on the potential vaccine candidates that are in…
Pressure to create a coronavirus vaccine is increasing by the day, but for a safe vaccine to enter the market, it takes time. USA TODAY As scientists race to develop a COVID-19 vaccine, some expert…
More than 140 teams of researchers are racing to develop a safe and effective coronavirus vaccine Thu 2 Jul 2020 07.22 EDT Last modified on Thu 2 Jul 2020 08.22 EDT Pre-clinical vaccines not yet in human trials 132 Phase 1 vaccines in small-scale safety trials 14 Phase 2 vaccines in expanded safety trials 8 Phase 3…
Masks and social distancing still necessary, says Johns Hopkins epidemiologist Caitlin Rivers. USA TODAY Amid concerns about coronavirus spikes caused by reopenings or mass protests, USA TODAYs Edi…
Chad Wolf, acting secretary of the Department of Homeland Security, hit back at a press conference in DHS headquarters in Washington, D.C. on Tuesday against media reports that the Trump administrati…
President Donald Trump raised an eye-popping $20 million on Tuesday night in his first-ever virtual fundraiser, from a total of more than 300,000 individual donors who participated. This is a great …
The American Civil Liberties Union (ACLU), as well as other migration lobbying organizations, claims it is “unconstitutional” not to count illegal aliens when apportioning congressional representatio…
The United States House of Representatives is set to vote on Wednesday on legislation reversing President Donald Trump's controversial ban on immigration from Muslim countries. The bill, called the …
